Marijuana’s current status under federal law impedes scientific studies into its medical benefits, the U.S.’s top official overseeing health research says.
“One problem for us the way in which Schedule I has been applied to marijuana, which means that doing research in that and in other Schedule I drugs can be extremely onerous for researchers,” Dr. Francis S. Collins, director of the National Institutes of Health (NIH), said during a U.S. Senate hearing on Tuesday. “The approvals take as long as a year to happen. One of the asks, I guess, if we had one in terms of a policy change, would be to provide special exemptions to allow more research to be done on Schedule I drugs.”
Under current law, marijuana is classified under Schedule I of the Controlled Substances Act. That’s the most restrictive category, one which is supposed to be reserved for drugs with a high potential for abuse and no medical value.
Collins, appearing before a Senate Appropriations subcommittee hearing about opioid issues, was responding to a question from Sen. Jeff Merkley (D-OR) about research indicating that states with legal marijuana access see lower overdose rates.
“There’s a correlation there,” Collins said. “The questions always is for epidemiologists, is a correlation a causation? Is there a connection there? We don’t know, but it’s a very intriguing finding.”
Noting that NIH is “very interested in pursuing this space,” Collins said that cannabinoid receptors in the brain are an intriguing area of study in developing alternative pain management approaches.
“Among the various strategies that we expect to explore in greater intensity this public-private partnership for identifying alternatives to opioids would be cannabinoids of various types that might produce pain relief without producing the other unfortunate side effects that people are concerned about with smoked marijuana,” he said.
In response to a separate question from Sen. Jerry Moran (R-KS), Collins said that while research was still ongoing, data so far is “encouraging” on marijuana’s potential to be an opioid alternative.
“I think most of this still remains pretty unclear in terms of what the actual benefits are and for which conditions, although there are certainly encouraging signs that this may well turn out to be rigorously and evidentially supported in many cases,” he said.
Earlier this year, the Senate Appropriations Committee directed the National Institute on Drug Abuse, part of NIH, to issue a report on the research roadblocks created by cannabis’s Schedule I status.
GOP Congressman: Legal Marijuana Has “Possibility To Create Jobs”
Legalizing marijuana might be a way to help lift rural areas of Virginia out of poverty, a Republican who represents part of the state in Congress says.
“The lands out in Southwest are conducive to be able to grow that for medicinal purposes, or whatever it is, for other research purposes, and even recreational use for some areas, if Virginia chooses to legalize it in that way,” Congressman Scott Taylor said on Wednesday. “And if Virginia goes that way I think there is the possibility to create jobs down in the Southwest.”
Taylor, who was answering a caller’s question during an appearance on C-SPAN’s Washington Journal, added that he supports letting states set their own cannabis laws without federal interference.
“I think we should decriminalize it and leave it up to the states,” he said. “I do believe it’s a state decision, not a federal decision.”
Taylor, a freshman member of Congress, is a cosponsor of a pending House bill to remove marijuana from the Controlled Substances Act.
“When I was in the state House we voted to legalize industrial hemp, which is also another product that would grow well in Southwest just as tobacco did,” Taylor added. “So I think there’s product there.”
Advocates believe that Virginia has a good chance of decriminalizing cannabis in 2018. Incoming Gov. Ralph Northam, A Democrat, spoke often about cannabis on the campaign trail, consistently describing criminalization’s impact in stark racial justice terms.
Republican Senate Majority Leader Tommy Norment has announced he will file a decriminalization bill when the new legislative session begins in January.
Vermont Will Legalize Marijuana Within Weeks, Officials Indicate
Vermont appears poised to become the next state to legalize marijuana. And, according to top elected officials, it is likely to do so within a matter of weeks.
Last week, House Speaker Mitzi Johnson, a Democrat, said she expects “it likely will pass in early January.” Days earlier, Gov. Phil Scott, a Republican, said he is “comfortable” signing a cannabis legalization bill into law in early 2018. And on Thursday, Senate President Pro Tempore Tim Ashe, a member of the Progressive Party, said he and his colleagues “look forward to working with the governor to make sure that that bill gets to the finish line.”
(Marijuana Moment’s editor provides some content to Forbes via a temporary exclusive publishing license arrangement.)
Photo courtesy of M a n u e l.
Here’s What Jeff Sessions Discussed In Secret With Anti-Marijuana Activists
Last week, U.S. Attorney General Jeff Sessions held a behind-closed-doors meeting about marijuana with anti-legalization activists.
Now, thanks to the fact that Sessions inadvertently showed an agenda for the meeting to a TV camera that was in the room to capture introductions — along with some high-tech sleuthing — we know what the prohibitionists discussed in secret after reporters were kicked out.
A Twitter user with the handle @MentalMocean was able to enhance a screen capture of the document that Marijuana Moment posted.
The document appears to read:
Bertha Madras: Marijuana is not a substitute for opiates as a pain medication.
Dr. Hoover Adger: The harm from today’s marijuana.
Dr. Bob DuPont: The effect of marijuana on drugged driving.
David Evans: The role that the Food and Drug Administration can and should [obscured]
[obscured] The organizations you can speak for and what you and they are [obscured] people from recreational marijuana use.
[obscured] law enforcement thinks of the commercialization of [obscured] law enforcement would support an enforcement initiative.
[obscured] course of marijuana commercialization in the states if the [obscured] not intervene.
The enhanced photo makes clear that the anti-legalization activists made a concerted pitch during meeting to convince Sessions to launch a federal crackdown on states that have ended cannabis prohibition.
Can any tech wizards enhance this screen grab of an agenda that Jeff Sessions was holding before the start of a drug policy meeting today? pic.twitter.com/7FLvjj1AZd
— Tom Angell 🌳📰 (@tomangell) December 8, 2017
— Sam Gold (@MentalMocean) December 13, 2017
In attendance, according to video of the opening introductions captured by a pool photographer and posted by C-SPAN, were:
- Edwin Meese III, U.S. attorney general under the Reagan administration
- Kevin Sabet, president and CEO of Smart Approaches to Marijuana
- Bertha Madras, a former Office of National Drug Control Policy staffer and a member of President Trump’s Commission on Combating Drug Addiction and the Opioid Crisis
- Robert DuPont, former director of the National Institute on Drug Abuse
- David Evans, executive director of the Drug Free Schools Coalition
- Dr. Hoover Adger, Johns Hopkins Hospital
“I think it’s a big issue for America, for the country, and I’m of the general view that this is not a healthy substance,” Sessions said at the beginning of the gathering. “I think that’s pretty clear. And then have the policy response that we and the federal government needs to be prepared to take and do so appropriately and with good sense.”
“I appreciate the opportunity to hear your analysis on marijuana and some of the related issues,” Sessions told the group. “I do believe, and I’m afraid, that the public is not properly educated on some of the issues related to marijuana. And that would be a matter that we could, all of us together, maybe be helpful in working on and that would allow better policy to actually be enacted.”
The group’s roundtable discussion itself, which took place after initial introductions, was closed to the press.
The gathering comes as the Justice Department’s overall position on marijuana policy remains uncertain. Sessions has in recent weeks sent mixed signals about his plans for federal marijuana enforcement under the Trump administration.
Last month, he testified before Congress that an Obama-era Justice Department memo that generally allows states to implement their own marijuana laws without interference remains in effect. But he separately told reporters at a briefing that his department is actively conducting talks about potential changes to the policy.
Photo courtesy of Gage Skidmore.
Politics2 months ago
This Obscure 45-Year-Old Federal Law Exempts State-Legal Marijuana
Politics2 weeks ago
Trump Administration Considering Marijuana Policy Changes, Sessions Says
Politics2 months ago
Former Surgeon General: Legalize Marijuana; Decrim Not Good Enough
Politics2 months ago
These States Will Probably Vote On Marijuana In 2018
Politics2 months ago
FDA To Review Medical Claims About Marijuana
Politics2 months ago
Marijuana Is A Big Issue In Next Month’s Elections
Politics3 weeks ago
New Sessions Memo: Does It Impact Marijuana?
Science & Health2 months ago
Psychologists Group Slams Barriers To Marijuana Research